Article
The potent broadly neutralizing antibody VIR-3434 controls Hepatitis B and D Virus infection and reduces HBsAg in humanized mice
2022-09-10
Abstract excerpt
<h4>Background & Aims</h4> Chronic hepatitis B is a major global public health problem, and coinfection with hepatitis delta virus (HDV) worsens disease outcome. Here, we describe a hepatitis B virus (HBV) surface antigen (HBsAg)-targeting monoclonal antibody (mAb) with the potential to promote functional cure of chronic hepatitis B and D to address this unmet medical need. <h4>Methods</h4> HBsAg-specific mAbs w...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5dca264c-0fd9-5e55-82ae-85df26ec488d
- DOI
- 10.1101/2022.09.09.507326
